The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review
- PMID: 32425606
- PMCID: PMC7196794
- DOI: 10.2147/CMAR.S245928
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review
Abstract
Despite the presence of many hematological prognostic indexes, clinical course and overall survival are often highly variable even within the same patient subgroup. Recent studies suggest that simple, cost-effective, low-risk tests such as neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ratio (LMR) may be used to evaluate the prognosis. Their role has been well confirmed in diffuse large B-cell lymphoma (DLBCL), Hodgkin lymphoma (HL) and multiple myeloma (MM), but until now the prognostic significance of NLR and LMR in leukemias has not been widely reported. In this article, we analyze the literature data on prognostic value of NLR and LMR in haematological malignancies in the context of classic prognostic factors and clinical course.
Keywords: Hodgkin lymphoma; lymphocyte to monocyte ratio; multiple myeloma; neutrophil to lymphocyte ratio; non-Hodgkin lymphoma.
© 2020 Stefaniuk et al.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this article.
Figures


References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical